Author

A. Donson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Assay:spatial transcriptomics· 2

Frequent Co-Authors

J. DeSisto· 3 shared R. Vibhakar· 3 shared A. Green· 2 shared K. A. Riemondy· 2 shared M. Handler· 2 shared N. Foreman· 2 shared N. Willard· 2 shared R. Fu· 2 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

J. DeSisto

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Multi-pronged analysis of pediatric low-grade glioma reveals a unique tumor microenvironment associated with BRAF alterations

S. Zahedi, K. A. Riemondy, A. M. Griesinger, A. Donson, R. Fu, M. Crespo, J. DeSisto, M. M. Groat, E. Bratbak, A. Green, T. C. Hankinson, M. Handler, R. Vibhakar, N. Willard, N. K. Foreman, J. M. Mulcahy Levy

This study uses multi-omics approaches to analyze pediatric low-grade glioma and identifies immune-related differences linked to BRAF mutations.

bioRxiv · Apr 5, 2024 · PreprintCancer Biology

Targeting Diffuse Midline Glioma with a novel anti-CD99 Antibody

I. Balakrishnan, K. Madhavan, A. M. Pierce, J. A. Michlin, B. Brunt, S. L. Chetty, D. Wang, J. DeSisto, Z. Nuss, N. Davidson, A. Donson, K. Jones, S. S. Mitra, A. Green, N. Dahl, , S. Venkataraman

This paper identifies CD99 as a therapeutic target in K27M+DMGs, showing that a novel anti-CD99 antibody reduces tumor growth and enhances radiation efficacy in preclinical models.

bioRxiv · Mar 19, 2024 · PreprintCancer Biology

Spatial transcriptomic analysis of childhood ependymoma implicates unresolved wound healing as a driver of tumor progression

R. Fu, G. Norris, N. Willard, A. Griesinger, K. A. Riemondy, V. Amani, E. Grimaldo, F. Harris, T. Hankinson, S. Mitra, t. Ritzmann, R. Grundy, N. Foreman, A. Donson

This study uses spatial transcriptomics to analyze childhood ependymoma, revealing unresolved wound healing as a driver of tumor progression through distinct cellular interactions and states.

bioRxiv · Mar 29, 2022 · PreprintCancer Biology

Comprehensive molecular characterization of pediatric treatment-induced high-grade glioma: A distinct entity despite disparate etiologies with defining molecular characteristics and potential therapeutic targets

J. DeSisto, J. T. Lucas, K. Xu, A. Donson, T. Lin, B. Sanford, Q. T. Tran, D. Hedges, C.-Y. Hsu, G. T. Armstrong, M. Arnold, S. Bhatia, P. Flannery, R. Lemma, L. Hardie, , A. L. Green

This study characterizes treatment-induced high-grade gliomas (TIHGGs) through molecular profiling, identifying distinct subgroups and potential therapeutic targets.

bioRxiv · Oct 29, 2019 · PreprintCancer Biology